{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:01:35Z","timestamp":1780455695382,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ijid.2021.09.041","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T02:43:40Z","timestamp":1632192220000},"page":"36-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Prevalence of resistance-associated substitutions and phylogenetic analysis of hepatitis C virus infection in Russia"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4417-8076","authenticated-orcid":false,"given":"Vasily","family":"Isakov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Hedskog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel O.","family":"Wertheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reilly E.","family":"Hostager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bandita","family":"Parhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7487-266X","authenticated-orcid":false,"given":"Adriano De Bernardi","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vithika","family":"Suri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Geivandova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vyacheslav","family":"Morozov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bessonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalya","family":"Gankina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Zhdanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dzhamal","family":"Abdurakhmanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evguenia","family":"Svarovskaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ijid.2021.09.041_bib0001","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3851\/IMP3266","article-title":"Sofosbuvir-based salvage therapy for HCV infection in cirrhotic patients with DAA failure and multidrug resistance","volume":"23","author":"Abdurakhmanov","year":"2018","journal-title":"Antivir Ther"},{"issue":"Suppl 1","key":"10.1016\/j.ijid.2021.09.041_bib0002","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/liv.13673","article-title":"Treatment of hepatitis C virus infection with direct-acting antiviral agents: 100% cure?","volume":"38","author":"Asselah","year":"2018","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.ijid.2021.09.041_bib0003","doi-asserted-by":"crossref","DOI":"10.1080\/22423982.2019.1648970","article-title":"Seroprevalence of markers of hepatitis C virus exposure and associated factors in adults aged 18-39 years in the Arctic Russian city of Arkhangelsk: a cross-sectional study","volume":"78","author":"Balaeva","year":"2019","journal-title":"Int J Circumpolar Health"},{"key":"10.1016\/j.ijid.2021.09.041_bib0004","doi-asserted-by":"crossref","unstructured":"Balzer, H. R., Maria. (2010). Migration between China and Russia. Post-soviet Affairs, POST-SOV AFF. 26. 1-37. 10.2747\/1060-586X.26.1.1.","DOI":"10.2747\/1060-586X.26.1.1"},{"issue":"6","key":"10.1016\/j.ijid.2021.09.041_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218852","article-title":"Zinc deficiency and advanced liver fibrosis among HIV and hepatitis C co-infected anti-retroviral naive persons with alcohol use in Russia","volume":"14","author":"Barocas","year":"2019","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.ijid.2021.09.041_bib0006","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/infdis\/jiy401","article-title":"Identification of a Novel Hepatitis C Virus Genotype From Punjab, India: Expanding Classification of Hepatitis C Virus Into 8 Genotypes","volume":"218","author":"Borgia","year":"2018","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2021.09.041_bib0007","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/jvh.12795","article-title":"Resistance characterization of ledipasvir and velpatasvir in hepatitis C virus genotype 4","volume":"25","author":"Camus","year":"2018","journal-title":"J Viral Hepat"},{"issue":"2","key":"10.1016\/j.ijid.2021.09.041_bib0008","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S2468-1253(18)30270-X","article-title":"Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission","volume":"4","author":"Cooke","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.ijid.2021.09.041_bib0009","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/bioinformatics\/btz646","article-title":"StrainHub: a phylogenetic tool to construct pathogen transmission networks","volume":"36","author":"de Bernardi Schneider","year":"2020","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.ijid.2021.09.041_bib0010","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofv043","article-title":"Two Distinct Hepatitis C Virus Genotype 1a Clades Have Different Geographical Distribution and Association With Natural Resistance to NS3 Protease Inhibitors","volume":"2","author":"De Luca","year":"2015","journal-title":"Open Forum Infect Dis"},{"issue":"12","key":"10.1016\/j.ijid.2021.09.041_bib0011","doi-asserted-by":"crossref","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","article-title":"Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review","volume":"5","author":"Degenhardt","year":"2017","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ijid.2021.09.041_bib0012","series-title":"Field surgery in local wars and conflicts","author":"Gumanenko","year":"2011"},{"issue":"1","key":"10.1016\/j.ijid.2021.09.041_bib0013","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0022-2143(99)90055-0","article-title":"Prevalence of mixed infection by different hepatitis C virus genotypes in patients with hepatitis C virus-related chronic liver disease","volume":"134","author":"Giannini","year":"1999","journal-title":"J Lab Clin Med"},{"issue":"1 Suppl","key":"10.1016\/j.ijid.2021.09.041_bib0014","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection","volume":"61","author":"Gower","year":"2014","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.ijid.2021.09.041_bib0015","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01844-18","article-title":"In Vitro Susceptibility of Hepatitis C Virus Genotype 1 through 6 Clinical Isolates to the Pangenotypic NS3\/4A Inhibitor Voxilaprevir","volume":"57","author":"Han","year":"2019","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.ijid.2021.09.041_bib0016","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/hep.27361","article-title":"Characterization of hepatitis C virus intergenotypic recombinant strains and associated virological response to sofosbuvir\/ribavirin","volume":"61","author":"Hedskog","year":"2015","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ijid.2021.09.041_bib0017","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz076","article-title":"Identification of 19 Novel Hepatitis C Virus Subtypes-Further Expanding HCV Classification","volume":"6","author":"Hedskog","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"Suppl 6","key":"10.1016\/j.ijid.2021.09.041_bib0018","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1186\/1471-2334-14-S6-S12","article-title":"Hepatitis C virus seroprevalence among people who inject drugs and factors associated with infection in eight Russian cities","volume":"14","author":"Heimer","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2021.09.041_bib0019","doi-asserted-by":"crossref","DOI":"10.1093\/ve\/vez041","article-title":"Hepatitis C virus genotype 1 and 2 recombinant genomes and the phylogeographic history of the 2k\/1b lineage","volume":"5","author":"Hostager","year":"2019","journal-title":"Virus Evol"},{"issue":"2","key":"10.1016\/j.ijid.2021.09.041_bib0020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/23744235.2018.1535186","article-title":"Sofosbuvir\/velpatasvir for the treatment of HCV: excellent results from a phase-3, open-label study in Russia and Sweden","volume":"51","author":"Isakov","year":"2019","journal-title":"Infect Dis (Lond)"},{"issue":"3","key":"10.1016\/j.ijid.2021.09.041_bib0021","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s40261-017-0606-0","article-title":"Ledipasvir-Sofosbuvir for 8 Weeks in Non-Cirrhotic Patients with Previously Untreated Genotype 1 HCV Infection +\/- HIV-1 Co-Infection","volume":"38","author":"Isakov","year":"2018","journal-title":"Clin Drug Investig"},{"issue":"8","key":"10.1016\/j.ijid.2021.09.041_bib0022","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3851\/IMP3065","article-title":"Efficacy of sofosbuvir plus ribavirin in treatment-naive patients with genotype-1 and -3 HCV infection: results from a Russian Phase IIIb study","volume":"21","author":"Isakov","year":"2016","journal-title":"Antivir Ther"},{"issue":"8","key":"10.1016\/j.ijid.2021.09.041_bib0023","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1128\/JVI.76.8.4034-4043.2002","article-title":"A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg","volume":"76","author":"Kalinina","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2021.09.041_bib0024","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jcv.2016.05.010","article-title":"New findings in HCV genotype distribution in selected West European, Russian and Israeli regions","volume":"81","author":"Kartashev","year":"2016","journal-title":"J Clin Virol"},{"issue":"10","key":"10.1016\/j.ijid.2021.09.041_bib0025","first-page":"62","article-title":"Pooled Resistance Analysis in Patients with Hepatitis C Virus Genotype 1 to 6 Infection Treated with Glecaprevir-Pibrentasvir in Phase 2 and 3 Clinical Trials","author":"Krishnan","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.ijid.2021.09.041_bib0026","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1128\/AAC.00054-12","article-title":"Genotype and subtype profiling of PSI-7977 as a nucleotide inhibitor of hepatitis C virus","volume":"56","author":"Lam","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.ijid.2021.09.041_bib0027","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1128\/AAC.00763-16","article-title":"Clinical Resistance to Velpatasvir (GS-5816), a Novel Pan-Genotypic Inhibitor of the Hepatitis C Virus NS5A Protein","volume":"60","author":"Lawitz","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"20","key":"10.1016\/j.ijid.2021.09.041_bib0028","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1056\/NEJMra1213651","article-title":"Current and future therapies for hepatitis C virus infection","volume":"368","author":"Liang","year":"2013","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ijid.2021.09.041_bib0029","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1086\/587992","article-title":"Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan","volume":"46","author":"Liu","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.041_bib0030","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3389\/fmicb.2019.00535","article-title":"Subtype-Specific Prevalence of Hepatitis C Virus NS5A Resistance Associated Substitutions in Mainland China","volume":"10","author":"Lu","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijid.2021.09.041_bib0031","doi-asserted-by":"crossref","first-page":"20282","DOI":"10.3402\/ijch.v72i0.20282","article-title":"Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study","volume":"72","author":"Makarova","year":"2013","journal-title":"Int J Circumpolar Health"},{"issue":"1","key":"10.1016\/j.ijid.2021.09.041_bib0032","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.27259","article-title":"Global distribution and prevalence of hepatitis C virus genotypes","volume":"61","author":"Messina","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.ijid.2021.09.041_bib0033","first-page":"51","article-title":"Hepatitis C in the Russian Federation: challenges and future directions","volume":"8","author":"Mukomolov","year":"2016","journal-title":"Hepat Med"},{"issue":"8","key":"10.1016\/j.ijid.2021.09.041_bib0034","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1073\/pnas.88.8.3392","article-title":"Nucleotide sequence and mutation rate of the H strain of hepatitis C virus","volume":"88","author":"Ogata","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.ijid.2021.09.041_bib0035","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/bioinformatics\/btg412","article-title":"APE: Analyses of Phylogenetics and Evolution in R language","volume":"20","author":"Paradis","year":"2004","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ijid.2021.09.041_bib0036","unstructured":"Pimenov NN Modern epidemiology of HCV in Russia and development of epidemiological control. PhD Thesis, M., 2019, 24P. (In Russian)"},{"issue":"3","key":"10.1016\/j.ijid.2021.09.041_bib0037","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","author":"Polaris Observatory","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.ijid.2021.09.041_bib0038","doi-asserted-by":"crossref","DOI":"10.3390\/v10100545","article-title":"Epidemiology and Elimination of HCV-Related Liver Disease","volume":"10","author":"Pradat","year":"2018","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.ijid.2021.09.041_bib0039","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1360-0443.2006.01317.x","article-title":"Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study","volume":"101","author":"Rhodes","year":"2006","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.ijid.2021.09.041_bib0040","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource","volume":"59","author":"Smith","year":"2014","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.ijid.2021.09.041_bib0041","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jhep.2017.05.027","article-title":"Origin, prevalence and response to therapy of hepatitis C virus genotype 2k\/1b chimeras","volume":"67","author":"Susser","year":"2017","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.ijid.2021.09.041_bib0042","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/cid\/ciu697","article-title":"Infrequent development of resistance in genotype 1-6 hepatitis C virus-infected subjects treated with sofosbuvir in phase 2 and 3 clinical trials","volume":"59","author":"Svarovskaia","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ijid.2021.09.041_bib0043","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/infdis\/jiv564","article-title":"L159F and V321A Sofosbuvir-Associated Hepatitis C Virus NS5B Substitutions","volume":"213","author":"Svarovskaia","year":"2016","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2021.09.041_bib0044","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s150100050005","article-title":"Mixed infection with two types of hepatitis C virus is probably a rare event","volume":"28","author":"Viazov","year":"2000","journal-title":"Infection"},{"key":"10.1016\/j.ijid.2021.09.041_bib0045","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.antiviral.2018.08.001","article-title":"HCV phylogenetic signature and prevalence of pretreatment NS5A and NS5B NI-Resistance associated substitutions in HCV-Infected patients in Mainland China","volume":"158","author":"Wei","year":"2018","journal-title":"Antiviral Res"},{"issue":"2","key":"10.1016\/j.ijid.2021.09.041_bib0046","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jhep.2017.03.014","article-title":"Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analyses","volume":"67","author":"Welzel","year":"2017","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.ijid.2021.09.041_bib0047","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jhep.2016.11.022","article-title":"Post-treatment resistance analysis of hepatitis C virus from phase II and III clinical trials of ledipasvir\/sofosbuvir","volume":"66","author":"Wyles","year":"2017","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.ijid.2021.09.041_bib0048","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/hep.29541","article-title":"Glecaprevir\/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and\/or prior treatment experience: A partially randomized phase 3 clinical trial","volume":"67","author":"Wyles","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ijid.2021.09.041_bib0049","doi-asserted-by":"crossref","first-page":"176","DOI":"10.14740\/gr1171","article-title":"Successful Hepatitis C Virus Eradication in a Hemodialysis Patient With 2k\/1b Chimera Genotype: A Case Report and Literature Review","volume":"12","author":"Zubkin","year":"2019","journal-title":"Gastroenterology Res"},{"key":"10.1016\/j.ijid.2021.09.041_bib0050","series-title":"Genetic algorithm approaches for the phylogenetic analysis of large biological sequence datasets under the maximum likelihood criterion","author":"Zwickl","year":"2006"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221007499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221007499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:04:06Z","timestamp":1761120246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971221007499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":50,"alternative-id":["S1201971221007499"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2021.09.041","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of resistance-associated substitutions and phylogenetic analysis of hepatitis C virus infection in Russia","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2021.09.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}